EmailHospital Circular 19/2009
Date Issued: 7 July 2009
Distribution: Public Hospitals, Private Hospitals
Subject: Jurisdictional Direct Order - Intravenous Immunoglobulin (IVIg)
To advise hospitals of updated arrangements for Jurisdictional Direct Order of Intravenous Immunoglobulin (IVIg)
Patients requiring IVIg for conditions that do not meet the “Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) in Australia” (the Criteria) will not have the IVIg subsidised under the National Blood Agreement. The Criteria can be found on the National Blood Authority Australia website.
The National Blood Authority has arrangements with two companies to facilitate the purchase of IVIg for the treatment of conditions not satisfying the Criteria. The Octapharma product Octagam® is available through DHL Exel by telephoning 1800 077 421 and the CSL Limited product Sandoglobulin NF Liquid® is available by telephoning 1800 063 892.
This circular updates the “Alternative Access to IVIg – Jursidictional Direct Orders (JDO)” notified in Circular 8/2008
Geoff Lavender
Director, Programs
